Skip to main content

Warnex Inks Deal with Canada to Develop Forensic Mitochondrial Pre-screen

NEW YORK (GenomeWeb News) – Warnex Pro-DNA Services today announced a contribution agreement with Canada's federal research and development organization to develop a pre-screening method for forensic mitochondrial DNA testing.

Under the deal, the National Research Council of Canada Industrial Research Assistance Program will provide Warnex Pro-DNA up to C$49,200 (US$48,000) in funding, as well as technical and business advisory services.

Based in Thunder Bay, Ontario, Warnex Pro-DNA is a subsidiary of Warnex, and is the only private Canadian laboratory offering short tandem repeat (STR), Y-STR, miniSTR, mitochondrial DNA, and its Pro-DNA Lead testing services for forensic testing applications, it said. Mitochondrial DNA testing, it added, is "crucial" in cases in which nuclear DNA testing cannot be done, including shed hair at crime scenes, degraded DNA in skeletal remains, and when there are insufficient amounts of nuclear DNA.

The method that Warnex Pro-DNA is developing "will provide a fast, accurate, and inexpensive way to screen crime scene samples, such as fingerprint lifts, and touch DNA samples for mitochondrial DNA analysis," Mark Busgang, president and CEO of Warnex, said in a statement.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.